Shares of Halyard Health Inc. (NYSE:HYH) saw unusually-strong trading volume on Friday . Approximately 970,479 shares traded hands during mid-day trading, an increase of 168% from the previous session’s volume of 362,416 shares.The stock last traded at $34.59 and had previously closed at $34.35.

Several analysts have weighed in on HYH shares. Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a research report on Friday, May 6th. Stephens started coverage on Halyard Health in a research report on Friday, April 8th. They issued an “overweight” rating for the company. Stifel Nicolaus boosted their price objective on Halyard Health from $32.00 to $37.00 and gave the company a “buy” rating in a research report on Tuesday, June 14th. JMP Securities reiterated a “buy” rating on shares of Halyard Health in a research report on Tuesday, April 12th. Finally, TheStreet upgraded Halyard Health from a “sell” rating to a “hold” rating in a research report on Friday, July 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. Halyard Health has an average rating of “Buy” and a consensus target price of $33.80.

The firm’s market capitalization is $1.61 billion. The company’s 50-day moving average price is $33.24 and its 200 day moving average price is $29.35.

Halyard Health (NYSE:HYH) last released its quarterly earnings results on Wednesday, May 4th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.19. The firm had revenue of $385 million for the quarter, compared to analysts’ expectations of $369.80 million. The business’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.51 EPS. Analysts expect that Halyard Health Inc. will post $1.66 EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in HYH. New York State Common Retirement Fund boosted its position in Halyard Health by 168.1% in the fourth quarter. New York State Common Retirement Fund now owns 147,992 shares of the company’s stock valued at $4,944,000 after buying an additional 92,791 shares in the last quarter. California Public Employees Retirement System boosted its position in Halyard Health by 9.4% in the fourth quarter. California Public Employees Retirement System now owns 162,745 shares of the company’s stock valued at $5,437,000 after buying an additional 14,000 shares in the last quarter. Rhumbline Advisers boosted its position in Halyard Health by 1.7% in the fourth quarter. Rhumbline Advisers now owns 103,441 shares of the company’s stock valued at $3,456,000 after buying an additional 1,710 shares in the last quarter. First Trust Advisors LP purchased a new position in Halyard Health during the fourth quarter valued at $1,234,000. Finally, Liberty Mutual Group Asset Management Inc. boosted its position in Halyard Health by 51.7% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 30,034 shares of the company’s stock valued at $1,004,000 after buying an additional 10,238 shares in the last quarter.

Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.